Premium
Blood group ABO polymorphism inhibits SARS‐CoV‐2 infection and affects COVID‐19 progression
Author(s) -
Yamamoto Fumiichiro,
Yamamoto Miyako,
MuñizDiaz Eduardo
Publication year - 2021
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/vox.13004
Subject(s) - library science , medicine , covid-19 , computer science , disease , infectious disease (medical specialty)